State of New Jersey Common Pension Fund D’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,720
Closed -$6.56M 1597
2023
Q4
$6.56M Buy
20,720
+1,872
+10% +$364K 0.02% 581
2023
Q3
$3.19M Hold
18,848
0.01% 840
2023
Q2
$4.09M Buy
18,848
+1,679
+10% +$360K 0.01% 736
2023
Q1
$3.12M Hold
17,169
0.01% 846
2022
Q4
$3.37M Hold
17,169
0.01% 786
2022
Q3
$3.86M Sell
17,169
-4,564
-21% -$924K 0.02% 709
2022
Q2
$2.75M Sell
21,733
-1,656
-7% -$190K 0.01% 908
2022
Q1
$2.96M Buy
23,389
+2,179
+10% +$245K 0.01% 1037
2021
Q4
$2.78M Sell
21,210
-4,806
-18% -$621K 0.01% 1335
2021
Q3
$3.18M Buy
26,016
+4,099
+19% +$473K 0.01% 997
2021
Q2
$2.5M Buy
+21,917
New +$2.56M 0.01% 1398

Other funds holding KRTX

State of New Jersey Common Pension Fund D's KRTX Position: Q1 2024 in Review

State of New Jersey Common Pension Fund D sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 20,720 shares — an estimated $6.56M sold.

State of New Jersey Common Pension Fund D first reported a position in KRTX in Q2 2021 and held it in 11 quarters. The position peaked at $6.56M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • State of New Jersey Common Pension Fund D reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 20,720 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.56M.
  • State of New Jersey Common Pension Fund D first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • State of New Jersey Common Pension Fund D's Karuna Therapeutics, Inc. Common Stock position peaked at $6.56M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2024, filed 2 May 2024.